PSC - Referências
1. Martins EB, Chapman RW. Sclerosing cholangitis. Curr Opin Gastroenterol 1995;11:452-6.
2. Chapman RWG, Arborgh B Å M, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-7.
3. van-Milligen-de-Wit AW, van-Deventer SJ, Tytgat GN. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. Am J Gastroenterol 1995;90(6):893-900.
4. Martins EB, Graham AK, Chapman RW, Fleming KA. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 1996;23:988-93.
5. Martins EB, Chapman RW, Marron K, Fleming KA. Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases. J Clin Pathol 1996;49:53-6.
6. Bansi DS, Fleming KA, Chapman RW. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. Gut 1996;38:384-9.
7. Martins E, Chapman RW. Sclerosing cholangitis. Curr Opin Gastroenterol 1996;12:466-70.
8. Hoffman CEE. Verchluss der gallewege durch verdickung wandungen. Arch Pathol Anat Physiol 1867;49:206-15.
9. Delbet P. Retrecissement du choledoque: cholecystoduodenostomie. Bull Mem Soc Nat Chir 1924;50:1144-6.
10. Lafourcade R. Deux observations d'obliteration cicatricielle du choledoque. Anastomose laterale entre le choledoque et le duodenum dans le premier cas. Recontruction par prothese avec tube de caoutchouc dans le second. Bull Mem Soc Nat Chir 1925;51:828-31.
11. Judd ES. Stricture of the common bile duct. Ann Surg 1926;84:404.
12. Miller RTJ. Benign stricture of common bile duct. Ann Surg 1927;86:296-303.
13. Holubitsky IB, McKenzie AD. Primary sclerosing cholangitis of the extrahepatic ducts. Can J Surg 1964;7:277-83.
14. Manesis JG, Sullivan JF. Primary sclerosing cholangitis. Arch Intern Med 1965;115:137-9.
15. Smith MP, Loe RH. Sclerosing cholangitis. Am J Surg 1965;110:239-46.
16. Lister TD. A specimen of diffuse ulcerative colitis with secondary diffuse hepatitis. Trans Pathol Soc Lon 1899;50:130-4.
17. Ross JR, Swarts JM. Hepatic dysfunction and cirrhosis in chronic ulcerative colitis. Gastroenterology 1948;10:81-95.
18. Anonymous. Cirrhosis and colitis. Br Med J 1949;1:189.
19. Kleckner MS, Stauffer MH, Bergen JA, et al. Hepatic lesions in the living patient with chronic ulcerative colitis as demonstrated by needle biopsy. Gastroenterology 1952;22:1147-52.
20. Kimmestiel P, Large HL, Verner HD. Liver damage in ulcerative colitis. Am J Pathol 1952;28:259-90.
21. Boden RW, Rankin JG, Goulston SJM, Morrow W. The liver in ulcerative colitis. The significance of raised serum alkaline phosphatase levels. Lancet 1959;2:245-8.
22. Palmer WL, Kirsner JB, Goldgraber MB, et al. Diseases of the liver in chronic ulcerative colitis. Am J Med 1964;36:856-66.
23. Stauffer MH, Sauer WG, Dearing WH, et al. The spectrum of cholestatic hepatic disease. Journal of the American Medical Association 1965;191:829-37.
24. Mistilis SP. Pericholangitis and ulcerative colitis. I. Pathology, etiology, and pathogenesis. Ann Int Med 1965;63:1-16.
25. de Dombal FT, Goldie W, Watts JMcK, et al. Hepatic histological changes in ulcerative colitis. A series of 58 consecutive operative liver biopsies. Scand J Gastroenterol 1966;1:220-7.
26. Eade MN, Brooke BN. Portal bacteraemia in cases of ulcerative colitis submitted to colectomy. Lancet 1969;1:1008-9.
27. Schwartz SI, Dale A. Primary sclerosing cholangitis. Review and report of 6 cases. Arch Surg 1958;77:439-51.
28. Warren R, Athanassiades S, Mohge JI. Primary sclerosing cholangitis; a study of forty-two cases. Am J Surg 1966;111:23-38.
29. Leevy CM, Popper H, Sherlock S. Diseases of the liver and biliary tract. Stansardisation of the nomenclature, diagnostic criteria and diagnostic methodology. Washington DC, US Government Printing Office.
30. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200-6.
31. Quigley EM, LaRusso NF, Ludwig J, MacSween RN, Birnie GG, Watkinson G. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1983;85(5):1160-5.
32. Aadland E, Schrumpf E, Fausa O, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987;22(6):655-64.
33. Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol 1994;21:1061-6.
34. Broome U, Glaumann H, Hellers G, Nilsson B, Sorstad J, Hultcrantz R. Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut 1994;35(1):84-9.
35. Aitola P, Karvonen AL, Matikainen M. Prevalence of hepatobiliary dysfunction in patients with ulcerative colitis. Ann Chir Gynaecol 1994;83:275-8.
36. Boberg KM, Schrumpf E, Fausa O, et al. Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis. Scand J Gastroenterol 1994;29(8):744-52.
37. Escorsell A, Pares A, Rodes J, Soli-Herruzo JA, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. J Hepatol 1994;21:787-91.
38. Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 1985;102(5):581-7.
39. Cohen RD, Hanauer SB. Protection from primary sclerosing cholangitis: smoke trails of just coattails?. Gastroenterology 1996;110:1658-62.
40. van-Erpecum KJ, Smits SJ, van-de-Meeberg PC, et al. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology 1996;110:1503-6.
41. Loftus EV Jr, Sandborn WJ, Tremaine WJ, et al. Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology 1996;110:1496-502.
42. Wiesner RH. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc 1994;69(10):969-82.
43. Ong JC, O'Loughlin EV, Kamath KR, Dorney SF, de-Silva M, Gaskin KJ. Sclerosing cholangitis in children with inflammatory bowel disease. Aust N Z J Med 1994;24(2):149-53.
44. Wilschanski M, Chait P, Wade JA, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995;22(5):1415-22.
45. Debray D, Pariente D, Urvoas E, Hadchouel M, Bernard O. Sclerosing cholangitis in children. J Pediatr 1994;124(1):49-56.
46. Olsson R, Danielsson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319-23.
47. Balasubramaniam K, Wiesner RH, LaRusso NF. Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 1988;95(5):1395-8.
48. Cullingford GL, Carr-Locke DL. Sclerosing cholangitis: variations in its clinical course. Eur J Gastroenterol Hepatol 1991;3:329-35.
49. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-5.
50. Boberg KM, Fausa O, Haaland T, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996;23:1369-76.
51. Kaw M, Silverman WB, Rabinovitz M, Schade RR. Biliary tract calculi in primary sclerosing cholangitis. Am J Gastroenterol 1995;90(1):72-5.
52. Jorgensen RA, Lindor KD, Sartin JS, LaRusso NF, Wiesner RH. Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis. J Clin Gastroenterol 1995;20(3):215-9.
53. Janczewska I, Ericzon BG, Eriksson LS. Influence of orthotopic liver transplantation on serum vitamin A levels in patients with chronic liver disease. Scand J Gastroenterol 1995;30(1):68-71.
54. Olsson RG, Asztely MS. Prognostic value of cholangiography in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 1995;7(3):251-4.
55. Broome U, Lofberg R, Veress B, Eriksson LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995;22(5):1404-8.
56. Brentnall TA, Haggitt RC, Rabinovitch PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996;110:331-8.
57. Loftus EV Jr, Sandborn WJ, Tremaine WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996;110:432-40.
58. Gurbuz AK, Giardiello FM, Bayless TM. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 1995;38(1):37-41.
59. Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10(4):430-6.
60. Farrant JM, Hayllar KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100(6):1710-7.
61. Dickson ER, Murtaugh PA, Wiesner RH, et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992;103(6):1893-901.
62. Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995;117(2):146-55.
63. Broome U, Eriksson LS. Assessment for liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 1994;20:654-9.
64. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995;108:865-9.
65. Nakeeb A, Lipsett PA, Lillemoe KD, et al. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 1996;171:147-52.
66. Rizzi PM, Ryder SD, Portmann B, Ramage JK, Naoumov NV, Williams R. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis. Gut 1996;38:265-8.
67. Nashan B, Schlitt HJ, Tusch G, et al. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 1996;23:1105-11.
68. Martins EB, Fleming KA, Garrido MC, Hine KR, Chapman RW. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1994;107(2):537-42.
69. Terada T, Nakanuma Y. Intrahepatic cholangiographic appearance simulating primary sclerosing cholangitis in several hepatobiliary diseases: a postmortem cholangiographic and histopathological study in 154 livers at autopsy. Hepatology 1995;22(1):75-81.
70. Van-Laethem JL, Deviere J, Bourgeois N, et al. Cholangiographic findings in deteriorating primary sclerosing cholangitis. Endoscopy 1995;27(3):223-8.
71. Ludwig JL, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981;1:632-40.
72. Olsson R, Hagerstrand I, Broome U, et al. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1996;48:933-5.
73. Allison MC, Burroughs AK, Noone P, Summerfield JA. Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study. J Hepatol 1986;3(1):118-22.
74. Burgert SL, Brown BP, Kirkpatrick RB, LaBrecque DR. Positive corticosteroid response in early primary sclerosing cholangitis. Gastroenterology 1984;86:1037.
75. Lindor KD, Wiesner RH, Colwell LJ, Steiner B, Beaver S, LaRusso NF. The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991;86(1):57-61.
76. Wiesner RH, Steiner B, LaRusso NF, Lindor KD, Baldus WP. A controlled clinical trial evaluating cyclosporine in the treatment of primary sclerosing cholangitis. Hepatology 1991;14:63A.
77. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988;95(4):1036-42.
78. Javett SL. Azathioprine treatment in primary sclerosing cholangitis. Lancet 1971;1:810.
79. Olsson R, Broome U, Danielsson A, et al. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 1995;108(4):1199-203.
80. Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994;106(2):494-9.
81. Lindor KD, Jorgensen RA, Anderson ML, Gores GJ, Hofmann AF, LaRusso NF. Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study. Am J Gastroenterol 1996;91:511-5.
82. Lo SK, Herrmann R, Chapman RW, et al. Ursodeoxycholic acid in primary sclerosing cholangitis: a double blind placebo controlled trial. Hepatology 1992;16:92A.
83. Jazrawi RP, de-Caestecker JS, Goggin PM, et al. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994;106(1):134-42.
84. O'Brien CB, Senior JR, Arora-Mirchandani R, Batta AK, Salen G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 1991;14(5):838-47.
85. Beuers U, Spengler U, Kruis W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992;16(3):707-14.
86. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 1994;20(1):57-64.
87. Stiehl A, Rudolph G, Sauer P, Theilmann L. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. J Hepatol 1995;23:283-9.
88. Van-Thiel DH, Carroll P, Abu-Elmagd K, et al. Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995;90(3):455-9.
89. Lee JG, Schutz SM, England RE, Leung JW, Cotton PB. Endoscopic therapy of sclerosing cholangitis. Hepatology 1995;21:661-7.
90. Myburgh JA. Surgical biliary drainage in primary sclerosing cholangitis. The role of the Hepp-Couinaud approach. Arch Surg 1994;129(10):1057-62.
91. Skolkin MD, Alspaugh JP, Casarella WJ, Chuang VP, Galambos JT. Sclerosing cholangitis: palliation with percutaneous cholangioplasty. Radiology 1989;170:199-206.
92. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995;22(2):451-7.
93. Lemmer ER, Bornman PC, Krige JE, et al. Primary sclerosing cholangitis. Requiem for biliary drainage operations? Arch Surg 1994;129(7):723-8.
94. Harrison J, McMaster P. The role of orthotopic liver transplantation in the management of sclerosing cholangitis. Hepatology 1994;20 (1 pt2):14S-9S.
95. Miki C, Harrison JD, Gunson BK, Buckels JA, McMaster P, Mayer AD. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation. Br J Surg 1995;82(8):1114-7.
96. Campbell WL, Sheng R, Zajko AB, Abu-Elmagd K, Demetris AJ. Intrahepatic biliary strictures after liver transplantation. Radiology 1994;191(3):735-40.
97. Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 1994;20(2):356-61.
98. Pappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995;19(2):192-206.
99. Sebagh M, Farges O, Kalil A, Samuel D, Bismuth H, Reynes M. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995;19(1):81-90.
Previous pages
Page 2
Page 3
Home
Email: ebmartins@trip.com.br
